JPRN-UMIN000043463已完成未知
A prospective observational study of Atezolizumab plus Bevacizumab in patients with unresectable hepatocellular carcinoma - ELIXIR
ational Cancer Center0 个研究点目标入组 510 人开始时间: 2021年3月1日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 510
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •(1) Patients with untreated or incompletely treated esophageal and/or gastric varices with bleeding or high-risk for bleeding*. *: Patients who underwent esophagogastroduodenoscopy (EGD) prior to enrollment and were judged to be at low risk of bleeding after assessment of all size of varices (small to large) can be enrolled in this study. *: Patients who have undergone EGD within 6 months of prior to initiation of Atezolizumab+Bevacizumab combination therapy do not need to perform the EGD again. (2) Patients who are judged unsuitable for enrollment into the study by the principal investigator or sub-investigator.
研究者
相似试验
进行中（未招募）
1 期
Study to assess efficacy of Atezolizumab in combination with Carboplatin Plus Pemetrexed in patients who are chemotherapy-naïve and have stage IV non-squamous non-small cell lung cancer with asymptomatic brain metastases (ATEZO-BRAIN)Atezolizumab combined with carboplatin and pemetrexedMedDRA version: 20.0Level: LLTClassification code 10025055Term: Lung cancer non-small cell stage IVSystem Organ Class: 100000004864EUCTR2017-005154-11-ESSpanish Lung Cancer Group (SLCG/GECP)40
进行中（未招募）
1 期
Atezolizumab and bevacizumab study for non small cell lung cancer patients with high-intermediate tumour mutation burdeon small cell lung cancerMedDRA version: 20.0 Level: PT Classification code 10061873 Term: Non-small cell lung cancer System Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2018-004654-17-ESFundación GECP102
进行中（未招募）
1 期
A Study of Atezolizumab in Patients with Locally Advanced, Unresectable Stage III Non-Small Cell Lung Cancer who have already received chemotherapy and radiotherapyon-Small Cell Lung Cancer (NSCLC)MedDRA version: 21.1Level: PTClassification code: 10029519Term: Non-small cell lung cancer stage III Class: 100000004864CTIS2023-503756-27-00F. Hoffmann-La Roche AG130
招募中
2 期
PhaseII study of Atezolizumab plus Chemotherapy in PS 2 Patients With Non-Sq NSCLCJPRN-jRCTs041210030Murakami Haruyasu20
进行中（未招募）
2 期
CCH1907/MK008 trialunresectable alveolar soft tissue sarcomaadvanced alveolar soft part sarcomaD018234JPRN-jRCT2031200041Yonemori Kan20